Fast Five Quiz: Non–Small Cell Lung Cancer (NSCLC) and the Epidermal Growth Factor Receptor Gene (EGFR)

Daniel S. Schwartz, MD, MBA


November 30, 2021

Figure 1. Color-enhanced chest radiograph of lung cancer.

Overexpression of EGFR is common in NSCLC. Cancers overexpressing EGFR have been shown to have increased resistance to therapy and increased metastatic potential, and thus a poorer prognosis.

Learn more about NSCLC and EGFR.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.